Skip to main content
OpenTrials

Clinical trial condition

Disease Attributes

Explore clinical trials studying Disease Attributes. Study availability and eligibility vary by location and protocol.

21,745 public trials 3,146 recruiting studies
Refine in advanced search Browse all conditions

Disease Attributes trial results

Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

NCT07221253

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +10 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Duarte, California, United States
View all 174 locations
View Trial Details
Recruiting

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

NCT05106387

Conditions
Chronic Disease, Chronic Kidney Disease (CKD), Disease Attributes, +10 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California Irvine Orange, California, United States
  • Connie Frank Transplant Center at UCSF San Francisco, California, United States
  • Yale University of Medicine New Haven, Connecticut, United States
View Trial Details
Recruiting

Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels

NCT06334575

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Philips University of Marburg Marburg, Germany
  • Academisch Ziekenhuis Groningen Groningen, Netherlands
  • Clínic Barcelona Barcelona, Spain
  • Son Espases Palma de Mallorca, Spain
View Trial Details
Recruiting

CAPABLE Transplant

NCT06326905

Conditions
Behavior, Behavioral Symptoms, Chronic Disease, +16 more
Locations
  • Johns Hopkins School of Nursing Baltimore, Maryland, United States
View Trial Details
Recruiting

A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])

NCT07208058

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
View all 18 locations
View Trial Details
Recruiting

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

NCT07046078

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
Locations
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions